Related Experiment Video
Updated: Sep 28, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis
Jiangfan Yu1, Rui Tang2, Ke Ding3
1Department of Dermatology, Second Xiangya Hospital of Central South University, Changsha, 410011, People's Republic of China.
Epigenetic factors like DNA methylation and non-coding RNAs are crucial in systemic sclerosis (SSc) pathogenesis. Understanding these epigenetic mechanisms, including exosomes and lncRNAs, offers potential biomarkers and therapeutic targets for SSc.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- Systemic sclerosis (SSc) is a rare, chronic autoimmune disease characterized by immune dysregulation, vascular damage, and fibrosis.
- The complex etiology of SSc involves genetic predisposition and environmental triggers.
- Epigenetic regulation is increasingly recognized as a key molecular mechanism influenced by environmental factors in SSc pathogenesis.
Purpose of the Study:
- To review current research on the role of epigenetics in systemic sclerosis.
- To explore specific epigenetic mechanisms, including DNA methylation, histone modification, and non-coding RNA regulation.
- To identify potential epigenetic biomarkers and therapeutic targets for SSc.
Main Methods:
- Literature review of recent advances in SSc epigenetics.
- Focus on key epigenetic regulators such as exosomes and long non-coding RNAs (lncRNAs).
- Analysis of studies investigating epigenetic alterations in SSc patients.
Main Results:
- Epigenetic modifications, including DNA methylation, histone modifications, and non-coding RNAs, significantly contribute to SSc development.
- Exosomes and lncRNAs are implicated as important mediators in SSc pathogenesis.
- Several epigenetic factors show promise as potential biomarkers for diagnosis and prognosis.
Conclusions:
- Epigenetic dysregulation is central to the pathogenesis of systemic sclerosis.
- Targeting epigenetic mechanisms, particularly exosome and lncRNA pathways, may offer novel therapeutic strategies for SSc.
- Further research into epigenetic biomarkers could improve SSc management.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
The JAK-STAT Signaling Pathway
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...

